Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anisodine hydrobromide for acute lacunar infarction
ChiCTR2000035411Phase 4Not yet recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of anisodine in lacunar infarct (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoint: Improvement of neural function and cognitive function. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
anisodine
03
Conditions
lacunar infarct
Beyond the preview
Go deeper on ChiCTR2000035411.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035411.